PRESTIGE CONSUMER HEALTHCARE
PBHNYSEEarnings Nov 4US Equity
$137.47▲ $5.90 (+4.29%)
Simulated price1h—
24h▲ 4.3%
7d—
14d—
30d—
1y—
🏦Market Cap
$268.66B
Large Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
60
Fair
No chart data available for PBH.
Trading Snapshot
- Day Range
- $136.08 – $140.02
- 52-Week Range
- —
- Volume
- $3.22B
- Avg Volume
- $3.72B
- Shares Outstanding
- —
- Next Earnings
- Sep 16, 2026
Fundamentals Snapshot
- Annual Revenue
- $25.11B
- Last Q Revenue
- $6.22B
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Why Investors Own PBH
- ✓High-growth profile — revenue up +31.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 63% gross margin and 24% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$25.11B▲ +33.7% YoY
Gross Margin (TTM)
62.8%▲ +3.2% YoY
Operating Income (TTM)
$5.32B▲ +33.7% YoY
Free Cash Flow (TTM)
$6.05B▲ +33.7% YoY
About PRESTIGE CONSUMER HEALTHCARE
A company profile for PRESTIGE CONSUMER HEALTHCARE isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
60/100
Analyst Price Target
ⓘAverage Target
$154.38
▲ +12.3% Upside
High Target$192.50
Low Target$130.60
Based on 21 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
PRESTIGE CONSUMER HEALTHCARE tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift PBH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Bloomberg·1d ago
PRESTIGE CONSUMER HEALTHCARE announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.